Leeward Investments LLC MA Sells 14,308 Shares of Option Care Health, Inc. $OPCH

Leeward Investments LLC MA lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 371,365 shares of the company’s stock after selling 14,308 shares during the quarter. Leeward Investments LLC MA’s holdings in Option Care Health were worth $12,062,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. US Bancorp DE increased its stake in Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after acquiring an additional 393 shares during the last quarter. Sheets Smith Wealth Management increased its stake in Option Care Health by 1.9% in the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock worth $810,000 after acquiring an additional 457 shares during the last quarter. State of Michigan Retirement System increased its stake in Option Care Health by 1.2% in the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company’s stock worth $1,425,000 after acquiring an additional 500 shares during the last quarter. Louisiana State Employees Retirement System increased its stake in Option Care Health by 1.1% in the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company’s stock worth $1,667,000 after acquiring an additional 500 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its stake in Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company’s stock worth $696,000 after acquiring an additional 525 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In other news, Director Norman L. Wright bought 3,411 shares of the stock in a transaction on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director owned 15,501 shares of the company’s stock, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 59,411 shares of company stock worth $1,627,576. 0.64% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on OPCH shares. JMP Securities lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. TD Cowen started coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating and a $30.00 price objective on the stock. Morgan Stanley began coverage on Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective on the stock. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Tuesday, September 23rd. Finally, Cowen began coverage on Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating for the company. Nine analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $35.10.

Option Care Health Price Performance

OPCH opened at $27.91 on Friday. The business has a fifty day moving average of $27.99 and a 200 day moving average of $30.09. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a market cap of $4.53 billion, a P/E ratio of 22.33, a PEG ratio of 1.69 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 EPS. Option Care Health’s revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.